Baird Remains Bullish on Sigma Designs (SIGM) Following 1Q Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Needham & Company Remains Bullish on Sigma Designs (SIGM) Following 1Q Earnings Report
June 7, 2016 8:04 AM EDTNeedham & Company reiterated a Buy rating and $13.00 price target on Sigma Designs (NASDAQ: SIGM) following the company's 1Q earnings report. SIGM reported revenue of $53.8MM, in-line with the midpoint of guidance. EPS was ($0.12). Reflecting strong growth in the Connected SmartTV business and a slight... More
After-Hours Stock Movers 06/06: (SRPT) (UNFI) (ZG) Higher; (DRYS) (MSTX) (ALXN) Lower (more...)
June 6, 2016 6:08 PM EDTToday's After-Hours Movers:
Sarepta Therapeutics (NASDAQ: SRPT) 26.7% HIGHER; announced that the FDA has requested that Sarepta provide dystrophin data, as measured by western blot, from biopsies already obtained from the ongoing confirmatory study of eteplirsen (PROMOVI), as part of its ongoing evaluation of the eteplirsen New Drug Application (NDA). The Company plans to submit data from thirteen patient biopsy samples, at baseline and Week 48, to the FDA over the coming weeks to facilitate a prompt decision on the NDA by the Agency.
DryShips (NASDAQ:... More
Sigma Designs (SIGM) Misses Q1 EPS by 7c
June 6, 2016 4:14 PM EDTSigma Designs (NASDAQ: SIGM) reported Q1 EPS of ($0.12), $0.07 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $53.8 million versus the consensus estimate of $53.9 million.
For earnings history and earnings-related data on Sigma Designs (SIGM) click here.
... MoreSigma Designs (SIGM) June volatility elevated into Q4 and outlook
June 6, 2016 7:38 AM EDTSigma Designs (NASDAQ: SIGM) June call option implied volatility is at 88, July is at 65; compared to its 52-week range of 42 to 101 into the expected release of Q1 results today after the market close.
... MoreTrading Radar for 6/6: Layne Christensen (LAYN), Xcerra (XCRA), United Natural Foods (UNFI), Thor (THO) Report
June 3, 2016 2:13 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Earnings:
Ability, Inc. (Nasdaq: ABIL) - consensus EPS $0.03
Xcerra (Nasdaq: XCRA) - consensus EPS... More
